BWA vs KALV · P/E 41, rev $7.18B vs rev $13.7M
BorgWarner Inc (BWA) versus Kalvista Pharmaceuticals Inc (KALV) — a side-by-side from cached financials, not a winner call.
BorgWarner Inc (BWA) is a auto parts company listed on NYSE.
Kalvista Pharmaceuticals Inc (KALV) is a biotechnology company listed on NASDAQ.
Latest reported BWA revenue for 2026-06-30 was $7.18B. Net income was $519.0M. BWA currently screens at market cap $14.47B and trailing P/E 41.0.
Latest reported KALV revenue for 2025-09-30 was $13.7M. Net income was -$158.9M. KALV currently screens at market cap $1.44B.
BWA currently screens at market cap $14.47B and trailing P/E 41.0. KALV currently screens at market cap $1.44B.
Not investment advice. Open the BWA and KALV stock pages for the full models.
Not investment advice.